Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
NVNO

NVNO - enVVeno Medical Corporation Stock Price, Fair Value and News

$10.23-0.04 (-0.39%)
Market Closed as of 11 Jun 2026, 04:00 pm ET

67/100

NVNO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

67/100

NVNO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

NVNO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NVNO Price Action

Last 7 days

-9.9%

Last 30 days

1.4%

Last 90 days

-10.9%

Trailing 12 Months

-91.6%

NVNO RSI Chart

NVNO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NVNO Valuation

Market Cap

6.7M

Price/Earnings (Trailing)

-0.36

Price/Sales (Trailing)

7.15

EV/EBITDA

-0.21

Price/Free Cashflow

-0.45

NVNO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

NVNO Fundamentals

NVNO Revenue

Revenue (TTM)

938.0K

Rev. Growth (Yr)

-44.13%

Rev. Growth (Qtr)

-5.93%

NVNO Earnings

Earnings (TTM)

-18.8M

Earnings Growth (Yr)

14.52%

Earnings Growth (Qtr)

-3.02%

NVNO Profitability

EBT Margin

-2075.91%

Return on Equity

-79.24%

Return on Assets

-72.11%

Free Cashflow Yield

-220.43%

NVNO Investor Care

Shares Dilution (1Y)

30.93%

Diluted EPS (TTM)

-31.25

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2026938.0K000
20251.7M1.5M1.3M1.1M
20241.4M1.6M1.9M1.6M
2023308.3K563.5K818.8K1.1M
202220.0K54.0K122.0K53.0K
20210000
20200000
2019186.7K0031.2K
2018363.2K304.3K245.4K186.6K
2017000422.1K
Get all data in R, Python etc through our Historical Stock Data APIs

About enVVeno Medical Corporation

NVNO
enVVeno Medical Corporation, a clinical med-tech company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of chronic venous disease. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
 CEO
 WEBSITEenvveno.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES30

enVVeno Medical Corporation Frequently Asked Questions

NVNO is the stock ticker symbol of enVVeno Medical Corporation. Every public company that trades on a stock exchange gets a ticker symbol.

As of Thu Jun 11 2026, market cap of enVVeno Medical Corporation is 6.71 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Thu Jun 11 2026, NVNO's PE ratio (Price to Earnings) is -0.36 and Price to Sales (PS) ratio is 7.15. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NVNO PE ratio will change depending on the future growth rate expectations of investors.